Company profile
nDatalyze Corp.
OTC: NDATF · Healthcare · Medical - Healthcare Information Services
Canadian filerHQ Calgary, ABReports USD
#1161 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
48DFH 61DQ —GM 22SS 19
v0.1 · 45/100 weight · provisional
↑ Altman-Z, balance-sheet leverage · ↓ workforce scale, revenue growth (YoY)
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
-$152.7k
Employees
1
as of 2026-08-24
Market cap
$3.3M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2026
Net income-$152.7k-212.0k CAD2026
Operating income-$157.4k-218.5k CAD2026
Total assets$250.9k342.3k CAD2026
Liabilities$13.3k18.1k CAD2026
Equity$237.6k324.2k CAD2026
Revenue trend
FY2019 – FY2026 · USD
FY19
FY20
FY21
FY22
FY23
FY24
FY25
FY26
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is nDatalyze Corp.’s revenue?
nDatalyze Corp. booked $0 in FY2026 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Stimcell Energetics, Inc.20DPharmaTher Holdings Ltd.——Quest PharmaTech Inc.——Elixxer Ltd.14DMoleculin Biotech, Inc.42DMedican Enterprises, Inc.——Key facts
CEOJames Morris Durward
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersCalgary, AB
ExchangeOTC: NDATF
Employees1
IPO date2021-07-15
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.